Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials - ScienceDirect
Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy | British Journal of Cancer
Progression-free survival as a surrogate endpoint of overall survival | OTT
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials | Haematologica
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Extrapolation from Progression-Free Survival to Overall Survival in Oncology - OHE
Progression-free survival and overall survival. Progression-free... | Download Scientific Diagram
Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450) - ScienceDirect
Extrapolation from Progression Free Survival to Overall Survival in O…
Progression-free survival and overall survival probabilities. | Download Scientific Diagram
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy | BMC Cancer | Full
How do doctors interpret differences between overall survival and progression free survival? - Quora
Progression-free survival and overall survival curves for all patients... | Download Scientific Diagram
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Progression-free survival (PFS) (A) and overall survival (OS) (B) based... | Download Scientific Diagram
Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer | British Journal of Cancer
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
A) Disease-free survival, (B) progression-free survival and (C)... | Download Scientific Diagram
Cancers | Free Full-Text | Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma
Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set | JCO Clinical Cancer Informatics
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
PPT - Overall Survival and Progression-Free Survival PowerPoint Presentation - ID:4064400
